Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy
© 2023 John Wiley & Sons Australia, Ltd..
OBJECTIVES: To evaluate longitudinal changes in lower urinary tract symptoms (LUTS) after artificial urinary sphincter (AUS) implantation in patients undergoing radiation therapy (RT) in comparison to those in non-irradiated patients.
METHODS: This retrospective study included 20 and 51 patients with and without a history of pelvic RT (RT and non-RT group, respectively) who were treated with primary AUS implantation for post-radical prostatectomy incontinence between 2010 and 2020. Longitudinal changes in the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), the International Prostate Symptom Score (IPSS), and the Overactive Bladder Symptom Score (OABSS) were calculated with a linear mixed model.
RESULTS: In the RT and non-RT group, 18 (90%) and 48 (94%) patients achieved social continence, defined as daily pad use ≤1 at 1 month after activation of AUS, respectively (p = .555). During the mean follow-up of 38 months, ICIQ-SF, IPSS, and OABSS significantly improved after AUS implantation in both the RT and non-RT groups. In the RT group, ICIQ-SF, IPSS, and OABSS subsequently deteriorated with a slope of 0.62/year (p = .010), 0.55/year (p = .025), and 0.30/year (p = .007), respectively. In the non-RT group, no significant longitudinal changes in subsequent IPSS and OABSS were observed, although ICIQ-SF significantly deteriorated (0.43/year, p = .006). Comparing between the groups, the slopes of IPSS and OABSS were significantly greater in the RT group than in the non-RT group (p < .001, and .015, respectively).
CONCLUSIONS: Longitudinal deterioration in LUTS that improved immediately after AUS implantation was observed in patients with a history of pelvic RT, but not in patients without a history of pelvic RT.
| Errataetall: |
ErratumIn: Low Urin Tract Symptoms. 2024 May;16(3):e12516. - PMID 38679472 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Lower urinary tract symptoms - 16(2024), 1 vom: 01. Jan., Seite e12507 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kataoka, Madoka [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Artificial urinary sphincter |
|---|
| Anmerkungen: |
Date Completed 30.01.2024 Date Revised 28.04.2024 published: Print-Electronic ErratumIn: Low Urin Tract Symptoms. 2024 May;16(3):e12516. - PMID 38679472 Citation Status MEDLINE |
|---|
| doi: |
10.1111/luts.12507 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364754680 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364754680 | ||
| 003 | DE-627 | ||
| 005 | 20240429231926.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/luts.12507 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1392.xml |
| 035 | |a (DE-627)NLM364754680 | ||
| 035 | |a (NLM)37984074 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kataoka, Madoka |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.01.2024 | ||
| 500 | |a Date Revised 28.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: Low Urin Tract Symptoms. 2024 May;16(3):e12516. - PMID 38679472 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 John Wiley & Sons Australia, Ltd. | ||
| 520 | |a OBJECTIVES: To evaluate longitudinal changes in lower urinary tract symptoms (LUTS) after artificial urinary sphincter (AUS) implantation in patients undergoing radiation therapy (RT) in comparison to those in non-irradiated patients | ||
| 520 | |a METHODS: This retrospective study included 20 and 51 patients with and without a history of pelvic RT (RT and non-RT group, respectively) who were treated with primary AUS implantation for post-radical prostatectomy incontinence between 2010 and 2020. Longitudinal changes in the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), the International Prostate Symptom Score (IPSS), and the Overactive Bladder Symptom Score (OABSS) were calculated with a linear mixed model | ||
| 520 | |a RESULTS: In the RT and non-RT group, 18 (90%) and 48 (94%) patients achieved social continence, defined as daily pad use ≤1 at 1 month after activation of AUS, respectively (p = .555). During the mean follow-up of 38 months, ICIQ-SF, IPSS, and OABSS significantly improved after AUS implantation in both the RT and non-RT groups. In the RT group, ICIQ-SF, IPSS, and OABSS subsequently deteriorated with a slope of 0.62/year (p = .010), 0.55/year (p = .025), and 0.30/year (p = .007), respectively. In the non-RT group, no significant longitudinal changes in subsequent IPSS and OABSS were observed, although ICIQ-SF significantly deteriorated (0.43/year, p = .006). Comparing between the groups, the slopes of IPSS and OABSS were significantly greater in the RT group than in the non-RT group (p < .001, and .015, respectively) | ||
| 520 | |a CONCLUSIONS: Longitudinal deterioration in LUTS that improved immediately after AUS implantation was observed in patients with a history of pelvic RT, but not in patients without a history of pelvic RT | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a artificial urinary sphincter | |
| 650 | 4 | |a lower urinary tract symptoms | |
| 650 | 4 | |a radiation therapy | |
| 700 | 1 | |a Yokoyama, Minato |e verfasserin |4 aut | |
| 700 | 1 | |a Waseda, Yuma |e verfasserin |4 aut | |
| 700 | 1 | |a Ito, Masaya |e verfasserin |4 aut | |
| 700 | 1 | |a Kobayashi, Masaki |e verfasserin |4 aut | |
| 700 | 1 | |a Fujiwara, Motohiro |e verfasserin |4 aut | |
| 700 | 1 | |a Nakamura, Yuki |e verfasserin |4 aut | |
| 700 | 1 | |a Ishikawa, Yudai |e verfasserin |4 aut | |
| 700 | 1 | |a Fukuda, Shohei |e verfasserin |4 aut | |
| 700 | 1 | |a Tanaka, Hajime |e verfasserin |4 aut | |
| 700 | 1 | |a Yoshida, Soichiro |e verfasserin |4 aut | |
| 700 | 1 | |a Masuda, Hitoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Fujii, Yasuhisa |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lower urinary tract symptoms |d 2009 |g 16(2024), 1 vom: 01. Jan., Seite e12507 |w (DE-627)NLM20000204X |x 1757-5672 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2024 |g number:1 |g day:01 |g month:01 |g pages:e12507 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/luts.12507 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2024 |e 1 |b 01 |c 01 |h e12507 | ||